semaglutide cardiovascular outcomes news 2025 protects the heart beyond weight loss, SELECT trial shows Cardiovascular Disease | Ozempic® (semaglutide)
Description
Learn what the latest studies are suggesting based on the most recent data.
Confused about where to start your metabolic health journey
This guide explains common coverage scenarios, out-of-pocket costs, and how compounded GLP-1 options may fit into your treatment strategy when branded medications aren't covered or accessible
The race to develop effective oral GLP-1 medications for obesity is heating up, and AstraZeneca is officially making its move
PlexusDx explains how injection timing affects appetite suppression, side effects, and treatment success while keeping your price stable at $149/month
